Recent progress in colon cancer tumor mutations profiling. Up to 500 tumor mutations are now tested, including KRAS, NRAS, BRAF and Microsatellite Instability (MSI) markers. New BRAF inhibitors (Sorafenib, Nexavar and Vemurafenib) are available to treat patients with BRAF-mutated colon cancer.
Precision medicine helps to select colorectal cancer patients with best treatments. Tumor markers play a crucial role in personalized treatment strategy for each patient. What are best tumor markers for colorectal cancer? Leading colorectal cancer chemotherapy expert discusses precision medicine treatment of colorectal cancer.